Full interview: EXMceuticals aiming to be 'largest volume and lowest cost' producer of CBD products
''The plan for the business, which we've already embarked on and are executing, is to grow large volumes of cannabis in Africa on an industrial scale, process that locally, refine it in Portugal and access all the end markets in North America and Europe.
''If you just look at Europe and ignore the rest of the world you have 750 million people who are increasingly interested and getting very excited about CBD as a health supplement and I think the potential for this industry and companies in this space, if they execute, could be very substantial''.
Quick facts: EXMceuticals
Market Cap: $43.34 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment...FOR OUR FULL DISCLAIMER CLICK HERE